148 related articles for article (PubMed ID: 1942641)
1. Prevention of the febrile reaction occurring on reinfusion of cell-free and concentrated autogenous ascites.
Katoh S; Tatsukawa H; Kondoh M; Inoue M; Ida K; Miyagawa F
Jpn J Med; 1991; 30(4):311-7. PubMed ID: 1942641
[TBL] [Abstract][Full Text] [Related]
2. Reinfusion of autogenous ascitic fluid concentrated by freezing in patients with intractable ascites.
Chiyoda S; Morikawa T; Matsuo K; Masuya S
Intern Med; 1992 Mar; 31(3):325-32. PubMed ID: 1611182
[TBL] [Abstract][Full Text] [Related]
3. Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration.
Yoshizawa M; Nakatsuji Y
Ther Apher Dial; 2019 Jun; 23(3):233-236. PubMed ID: 31033153
[TBL] [Abstract][Full Text] [Related]
4. Non-machinery-based system for cell-free, concentrated autogenous ascitic fluid reinfusion.
Katoh S; Kojima T; Morimoto S; Inoue K; Ida K; Nakaji S
Int J Artif Organs; 1995 Jul; 18(7):399-406. PubMed ID: 8655226
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
[TBL] [Abstract][Full Text] [Related]
6. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
Zaak D; Paquet KJ; Kuhn R
Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
[TBL] [Abstract][Full Text] [Related]
7. Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites.
Rossaro L; Graziotto A; Bonato S; Plebani M; van Thiel DH; Burlina A; Naccarato R; Salvagnini M
Dig Dis Sci; 1993 May; 38(5):903-8. PubMed ID: 8482189
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
Tsubokura M; Adegawa Y; Kojima M; Tanosaki R; Ohtake R; Kase Y; Iwashita N; Kasane M; Nakabayashi S; Takeuchi S; Kato K; Boku N; Kanemitsu Y; Okusaka T; Fujimoto H; Yonemori K; Ishiki H; Kawamura K; Satomi E; Matsushita H
BMC Cancer; 2022 Mar; 22(1):268. PubMed ID: 35287609
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites.
Fukunaga S; Egawa M; Ito T; Tanabe K
J Artif Organs; 2024 Jun; 27(2):138-145. PubMed ID: 37178240
[TBL] [Abstract][Full Text] [Related]
10. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
11. Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluid.
Villeneuve JP; Thuot C; Marleau D; Joly JG; Huet PM; Viallet A
Can Med Assoc J; 1977 Dec; 117(11):1296-8. PubMed ID: 72594
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of cancer ascites by combined intraperitoneal administration of low-dose CDDP and reinfusion of ultra-filtrated and concentrated ascitic fluid in patients].
Takahashi Y; Imai H; Ikawa A; Yasuda K; Kawai M; Yamamori T; Furuichi N; Misawa K; Ohashi H
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1820-4. PubMed ID: 10560403
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
[TBL] [Abstract][Full Text] [Related]
14. Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis.
Kozaki K; IInuma M; Takagi T; Fukuda T; Sanpei T; Terunuma Y; Yatabe Y; Akano K
Ther Apher Dial; 2016 Aug; 20(4):376-82. PubMed ID: 27523078
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.
Hanafusa N; Isoai A; Ishihara T; Inoue T; Ishitani K; Utsugisawa T; Yamaka T; Ito T; Sugiyama H; Arakawa A; Yamada Y; Itano Y; Onodera H; Kobayashi R; Torii N; Numata T; Kashiwabara T; Matsuno Y; Kato M
PLoS One; 2017; 12(5):e0177303. PubMed ID: 28510606
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of ascites with reinfusion of ascitic fluid concentrate].
Narwan H; Demes M; Kovac A; Danninger F
Bratisl Lek Listy; 2000; 101(5):306-9. PubMed ID: 11039198
[TBL] [Abstract][Full Text] [Related]
17. Biochemical evaluation of processed ascites in patients undergoing cell-free and concentrated ascites reinfusion therapy.
Nakamura H; Hanafusa N; Kitamura K; Nakamura H; Sekihara H; Shimizu K; Anayama M; Makino Y; Tamura K; Nagasawa M
Ther Apher Dial; 2020 Oct; 24(5):516-523. PubMed ID: 32524759
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel automatic ascites filtration and concentration equipment with multi-ring-type roller pump units for cell-free and concentrated ascites reinfusion therapy.
Okahisa T; Sogabe M; Nakagawa T; Tanaka K; Tomonari T; Taniguchi T; Takahashi A; Kinouchi Y; Nishioka J; Igata N; Yanagawa H; Komatsu T; Ohnishi Y; Fukuhara M; Ishikawa M; Shibata H; Shinomiya H; Nakasono M; Kishi F; Komai K; Tatsuki Y; Murashima T; Deguchi Y; Aramaki H; Fukumitsu H; Takayama T
Artif Organs; 2020 Aug; 44(8):856-872. PubMed ID: 32187379
[TBL] [Abstract][Full Text] [Related]
19. A study of appropriate flow rate settings for cell-free and concentrated ascites reinfusion therapy and change of cytokine concentrations in ascites.
Orimi S; Mizuno K; Narahara M; Umakosi H; Kaihara M; Hashimoto M
Ther Apher Dial; 2011 Aug; 15(4):411-4. PubMed ID: 21884478
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.
Ito T; Hanafusa N; Soneda N; Isoai A; Kobayashi R; Torii N; Kato M
J Gastroenterol Hepatol; 2021 Nov; 36(11):3224-3232. PubMed ID: 34250635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
